Organization Overview
Alternative names
betamethasone (celestone) (1 trial)
bevacizumab (avastin) (1 trial)
bortezomib (velcade) (1 trial)
dexmedetomidine (precedex) (1 trial)
fluorouracil (efudex) (1 trial)
Acquired Immunodeficiency Syndrome (Phase 4)
Adenocarcinoma (Phase 2)
Breast Neoplasms (Phase 3)
Breech Presentation (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Small Cell (Phase 2)
Chronic Pain (Phase 4)
Colonic Neoplasms (Phase 4)
Communicable Diseases (Phase 4)
Conjunctivitis (Phase 2)
Cysts (Phase 2)
Esophageal Neoplasms (Phase 4)
HIV Infections (Phase 4)
Infections (Phase 4)
Infertility (Phase 1)
Kidney Diseases (Phase 2)
Liver Diseases (Phase 2)
Lung Neoplasms (Phase 2)
Lymphohistiocytosis, Hemophagocytic (Phase 3)
Multiple Myeloma (Phase 4)
Neoplasm Metastasis (Phase 4)
Neoplasms, Plasma Cell (Phase 4)
Neoplasms, Second Primary (Phase 4)
Neuroendocrine Tumors (Phase 2)
Osteogenesis Imperfecta (Phase 1)
Ovarian Hyperstimulation Syndrome (Phase 1)
Pancreatic Neoplasms (Phase 2)
Placental Insufficiency (Phase 3)
Polycystic Kidney, Autosomal Dominant (Phase 2)
Polycystic Kidney Diseases (Phase 2)
Pre-Eclampsia (Phase 3)
Pregnancy Complications (Phase 3)
Recurrence (Phase 4)
Respiratory Insufficiency (Phase 4)
Small Cell Lung Carcinoma (Phase 2)
Stomach Neoplasms (Phase 4)
Stroke (Phase 4)
Thrombosis (Phase 3)
Ulcer (Phase 2)
Varicose Ulcer (Phase 2)